In this study, copper, as one of the essential trace elements in the human body, was introduced into calcium polyphosphate (CPP) to prepare a novel scaffold in bone tissue engineering: copper-doped calcium polyphosphate (CCPP) scaffolds. This novel scaffold was characterized by XRD, FTIR and SEM. The porosity and mechanical properties of CCPP scaffolds were also investigated. Finally, its bioactivity and degradation behavior in vitro were exploited. The results suggested that low-content copper doping had no significant influence on the structure of CPP. The compressive strength of CCPP with 70% porosity was 5-9 MPa which met the strength requirements of cancellous bone (2- hydroxyapatite. The results obtained in our study suggest that 0.05% CCPP scaffold is a promising biomaterial for bone repairing applications.
Introduction
More and more orthopedic problems are becoming more devastating and costly with an aging population and prolonged life expectancy. Thus, there is a great need for a great quantity of bone replacement materials with excellent properties. However, at present there are no heterologous or synthetic bone substitutes available that have superior or even the same biological or mechanical properties compared to bone. Therefore, there is a necessity to develop novel treatments or improve the performance of synthetic bone substitutes. Over the years, some synthetic bone scaffolds have been investigated to repair damaged bone tissue and to overcome the lack of donor tissue.
The ideal scaffolds for bone repair should possess not only biocompatibility, osteoconductivity and osteoinductivity, but also the degradation characteristics and the ability to stimulate angiogenesis. [1] [2] [3] Angiogenesis plays an important role in bone formation and has great effects on bone defect repair. 4 Bioactive scaffolds, such as bioceramics, are ideal bone substitute materials, but the clinical success of these synthetic gras could not be achieved. 5 So, research is ongoing to improve the mechanical properties and biocompatibility of scaffolds, to promote osteoblast adhesion, growth and differentiation, and to allow vascular ingrowth and bone-tissue formation.
As a kind of bioactive scaffolds, bioceramics and bioactive glasses are known to have osteoconductive properties and thus are potential bone substitute materials. Phosphate-based ceramics are a range of ceramics made up of components which all occur naturally in the body. More interestingly, their dissolution rates can be tailored to suit with their end application simply by varying the compositions of the ceramics. 6, 7 As a kind of phosphate-based ceramics, biodegradable calcium polyphosphate (CPP) has been designed as gras for bone repairing, growth or substitution because of its mechanical strength, stable physicochemical properties, excellent biocompatibility and controllable degradability. 8 In a way, the energy produced by the breakage of P\O\P bonds between [PO 3 À ] units in CPP, which was similar to the breaking of high-energy anhydride linkages in the adenosine triphosphate, could be used for cell-growth. This could be the reason why the cytocompatibility of CPP were prior to HA and TCP. 9 Although CPP scaffolds possess generally controllable degradability and outstanding biocompatibility, their angiogenesis seem to be not prominent. Therefore, various approaches have been developed to enhance angiogenesis-ability of synthetic scaffolds such as HA, CPP and bioactive glasses. Among these approaches, the doping of bioceramic scaffolds with small quantities of bioinorganic ions is gaining increasing interest as an alternative way to the delivery of angiogenic growth factors for stimulating angiogenesis and osteogenesis. [10] [11] [12] Compared to growth factors, the bioinorganic angiogenic factors such as metal ions released from scaffolds can have some great superiorities, such as high stability and lower costs. Specically, it was reported that copper (Cu 2+ ) ions could promote angiogenesis through stabilising the expression of hypoxia-inducible factor (HIF-1a), thus mimicking hypoxia, which is very important in the differentiation and recruitment of cells and in formation of neovascularization. 11, 13 Moreover, copper exerts a critical role in degradation of extracellular matrix (ECM) and ECM remodeling by regulating gene expression, protein levels and activities of MMPs.
14 Copper has also been reported to have an osteogenic inuence in promoting the differentiation of osteoblastic cells and MSCs. 15, 16 However, the concentrations of copper ion exceeding optimal level can lead to cytotoxicity due to the production of free radical species, and bring about the risk of neurodegenerative diseases. 17, 18 Hence, in order to determine the optimal dose of copper introduced into scaffolds, the research on the degradation of Cu-doped scaffold and how it correlates with the texture of the materials are very important, which are also key considerations for their applications in tissue engineering.
In recent years, several biomaterials containing Cu have been developed and investigated to study the benets of copper ions on stimulating angiogenesis. Nevertheless, the direct incorporation of Cu ions into CPP scaffolds has not been investigated to date. Thus, this study was undertaken to create CPP scaffolds with varying amounts of Cu and assess the effects of Cu in CPP on the performance of scaffolds and activity of cells (osteoblasts and endothelial cells). Moreover, as mentioned above, in order to understand the degradation property of CCPP which plays an important role in the successful and long-term implantation of bone-repairing biomaterials, the degradation behaviors of CCPP in vitro (include the solution-mediated and osteoblast-mediated) were also investigated. By analyzing the results obtained from this research, we can provide the theoretical basis for the clinical application of CCPP. By doping copper ions into CPP, we provide a way to improve the properties of bioceramics and offer a novel idea on the application of bone repair materials. Also, we believe that it may give inspiration to others worked on the bone repair materials, draw their attention to CPP and CCPP scaffolds and extend the applications and development of bone tissue engineering.
Materials and methods

Preparation of porous CPP and CCPP scaffolds
Chemical precipitation method was used in our research to prepare the CCPP powders. CPP scaffolds and CCPP scaffolds with various amount of Cu were prepared in the following way: CaCO 3 and CuCO 3 were dissolved in 2 M phosphoric acid solution, and then stirred several minutes until the starting powders were completely dissolved. Subsequently, the solution was transferred to rotary evaporation apparatus and was evaporated in vacuum. Then, the resulting white precipitates were ltered, the distilled water was used to wash the precipitates until the pH of ltrate was 7. The precipitates were dried for 10 hours by infrared heat lamp to form the powders. In order to prepare CCPP, these powders were rst calcined at 500 C for 10 h, and then were melted by heating to 1200 C. The melt was quickly quenched on frozen water to obtain the bluish transparent frits. The amorphous frits were ground and screened to yield powders (<75 mm), then the powders were pressed at 98 MPa aer mixing with the stearic acid and 3 wt% poly(vinyl alcohol) additive, nally sintered for 1 h at 800 C to obtain porous CCPP cylinder (10 mm diameter and 2 mm thickness). Porous CPP scaffolds were prepared similar to CCPP scaffold and served as controls. The mass of CaCO 3 and CuCO 3 with various Cu/Ca molar ratios using in this study are listed in Table 1 . 2) were added to the collected solution to remove the organic compounds before testing by ICP-MS. The scaffolds needed to be soaked in pancreatin, washed with PBS and dried at 50 C to remove cells covered on the scaffolds before testing by SEM. Also, the weights of scaffolds, before and aer degrading, needed to be recorded to calculate the weight loss in solution-mediated degradation and osteoblast-mediated degradation. At predetermined time, the samples were rinsed in distilled water and dried in vacuum at 50 C before weighting. The percentage of weight loss was calculated by the following equation:
where W 0 is the initial weight of the sample and W t is the weight of the dried sample at time t.
The cytocompatibility of CCPP scaffolds with MG63 (human osteoblasts) and HUVEC (human umbilical vein endothelial cells)
MTT assay was carried out to evaluate the effect of CCPP scaffolds on proliferation of MG63 and HUVEC. In brief, sterilized CPP and various CCPP scaffolds were soaked in a culture medium for 24 h at 37 C and then MG63 were cultured on each scaffold in the 96-well plate for 2, 4, 6, 14 and 21 days, while HUVEC were cultured on each sample in an another 96-well plate for 2, 4 and 6 days. At the predetermined time, the plate was added with 20 ml per well of MTT solution (5 mg ml À1 in PBS) and then incubated at 37 C for 4 h to form formazan crystals. Aer that, the medium was sucked off and 200 ml of dimethyl sulfoxide was added into each well to dissolve the formazan crystals. The optical density at 492 nm was measured by a microplate reader (Model 550, Bio Rad Corp. USA). Furthermore, the growth and distribution of MG63 and HUVEC on CPP and CCPP scaffolds aer 4 days were investigated by uorescence microscope. Cells with a density of 6 Â 10 4 ml À1 were seeded on the scaffolds in the 24-well plate. Aer 4 days, the medium was all siphoned off and the scaffolds were washed by PBS solution (0.01 mol l À1 , pH ¼ 7.4). Then, 400 ml of uorescein diacetate (FDA) solution (10 mg ml À1 ) was added to the 24-well plate. Aer incubated at 37 C for 5 minutes, the solution] and incubated at 37 C in a humidied atmosphere (5% CO 2 in 95% air). Until conuence, cells were passaged at a 1 : 2 split ratio following trypsinization with 0.25% trypsin (Gibcobrl). Cells from passage 3 were used for the related experiments.
The effects of CPP and CCPP scaffolds on osteogenic and angiogenic growth factors secretion from osteoblasts/ endothelial cells
The effects of CPP and CCPP scaffolds on osteogenic and angiogenic growth factors secretion from osteoblasts/ endothelial cells were determined using a double ligand enzyme-linked immunosorbent assay (ELISA). MG63 and HUVEC cells were cultured and seeded on CPP and CCPP scaffolds with the same way mentioned above. Aer incubated at 37 C for 6 days, supernatant liquid was collected for ELISA assay through centrifugation and the effects of CPP scaffolds with varying amounts of Cu on vascular endothelial growth factor (VEGF) secretion from HUVEC and secretion of alkaline phosphatase (ALP), VEGF and osteocalcin (OCN) from MG63 were evaluated by ELISA. ELISA assay was run according to the manufacturer's instructions (R&D Corp.). A standard curve was plotted to determine the VEGF, ALP, and OCN concentration.
Statistical analysis
Statistical analysis was performed with SPSS 13.0. Experimental data was presented as means AE standard deviation (SD). Results were analyzed by one-way ANOVA with a student's t-test. A p value of <0.05 was considered to be statistically signicant.
Results and discussion
3.1 Characterization of CPP and CCPP scaffolds while, we also found that the amorphous frits could not form the scaffolds when sintering at high temperature more than 820 C. Therefore, the CCPP-samples sintering at temperature less than 550 C or more than 820 C could not be used as bone tissue repairing scaffolds. Fig. 1 Fig. 1(D) , the CCPP-samples presented more perfect crystallization aer sintering at 800 C, so we preferred to prepare b-CCPP at 800 C in subsequent experiments. Fig. 2 shows the FTIR spectra of CPP, 0.05% CCPP and 0.5% CCPP scaffolds. All the samples in Fig. 2 and "O-P-O", respectively. It indicated that there were no effect on the FTIR spectra of scaffolds aer incorporating into lowcontent copper ions. Fig. 3 shows the SEM images of CPP and CCPP scaffolds. As shown in gure, doping low-content copper ions into CPP had little effect on microstructure of scaffolds. The three dimensional interconnected porosity which satised requirement of cells growth and nutrient/metabolic waste transportation were well-preserved. Meanwhile, compared to CPP, the crystal grains of CCPP became tiny and intimately connected with each other. Therefore, CCPP possessed a more compact bulk, which might lead to better mechanical properties.
The porosities of CCPP scaffolds measured by liquid displacement method were shown in Table 3 which were similar to the results of the literature. 21 The compressive strength of CCPP scaffold with the porosity of 70% was 5-9 MPa which met the strength requirements of cancellous bone (2-12 MPa). It indicated that this CCPP scaffold could serve as a promising candidate for bone repairing. In this paper, it would be used as test-sample in subsequent experiments. Meanwhile, the compressive strength of CCPP scaffold without pore-forming agent was closed to the compressive strength of human femur (170 MPa vs. 197 MPa). Based on it, the CCPP scaffold without pore-forming agent might be applied as a potential compact bone material.
Degradation of CCPP scaffolds
In general, it is difficult to administer test condition and provide a good repeatability in investigation on the degradation behaviors of biomaterial-gras in vivo. However, the research on the degradation behavior of biomaterials in vitro is benecial to know the degradation behavior of these biomaterials in vivo. The degradation rate in vitro could be helpful to predict the degradation rate in vivo, and unsuitable degradation rate might directly affect the bone healing. So the degradation behavior of biomaterial-gras in vitro can establish a concrete foundation for investigating their degradability, and thus can provide guidance for the development of biomaterials with good properties. It is also one of very important factors to determine the feasibility to be used as bone repairing materials or bone tissue engineering scaffolds.
3.2.1 Analysis of the weight loss and ion release of CCPP scaffolds during SBF solution-mediated degradation. Fig. 4 shows the weight loss curve of various CCPP in SBF solution. The weight loss curves of all scaffolds showed the same trends: a quicker increase at earlier times was followed by a slower increase thereaer and to a nearly constant value at longer times. When the reaction was terminated at 30 days, the nal weight loss of scaffolds in SBF solution were 10-16%. In addition, it is obvious that doping copper ions into CPP had impact on degradation behavior of scaffolds when the content of copper was 0.5%. At any time, the weight loss of 0.5% CCPP was much larger than CPP. However, there were no signicant differences in weight loss between CCPP scaffolds doped lowcontent copper ions (0.01% and 0.05%) and CPP scaffold. , Cu 2+ and PO 4 3À released into the medium from 0.2% CCPP and 0.5% CCPP was more than that from 0.01% CCPP and 0.05% CCPP. As reported, lots of factors, such as the crystal structure, 22 sintering time and temperature, 23 polymerization degree, 24 ion doped 25 and degradation media, 26 could affect the degradation process of CPP. According to the methods during preparation and degradation experiment in this paper, some factors, such as the crystal structure, sintering time and temperature and polymerization degree of scaffolds must be similar due to the specicity of the preparation process of b-CCPP. So, we mainly discussed the effects of ion doped and degradation media on the degradation process of scaffolds in this paper. From our results above, we found that doping copper ions into CPP had some effects on degradation behavior of scaffolds. Compared to CPP, the crystal grains of CCPP became tiny and intimately connected with each other, but at the same time, doping copper could induce point defects due to the fact that copper ion radius was bigger than calcium ion radius. 27 The point defects could result in the changes in degradation behavior of scaffolds. The much the amount of doped copper ions is, the more signicant the point defects of scaffolds is. Therefore, CCPP scaffolds doped high-content copper ions (0.2% and 0.5%) had a faster degradation rate than CCPP scaffolds doped low-content copper ions (0.01% and 0.05%) and CPP scaffold. According to it, maybe we could control the degradation rate of CCPP scaffolds through adjusting the amount of copper ions doping into CPP. Fig. 6 , the weight loss of all scaffolds in both group increased continuously with time. Scaffolds in cell group showed a higher degradation rate than those in control group without cell. When the degradation was terminated aer 3 weeks, the weight loss of scaffolds in cell group (9.2%) was larger than that in control group without cell (6.2-8.0%). This result could be explained by the reason that the acidic environment created by the acidic metabolites secreted by osteoblasts could accelerate the degradation of scaffolds. Firstly, the porosity of scaffolds could become higher due to the acid condition, which might result in a higher surface area and lead to higher dissolution rate. Secondly, the break of covalent bonds in scaffolds induced by the acid condition could also increase the degradation rate of scaffolds. Finally, the pyrophosphatase, alkaline phosphatase and other acidic enzyme secreted by osteoblasts could also enhance the dissolution of scaffolds in cell group, and thus speed of the degradation of scaffolds in cell group. The degradation of CCPP scaffolds in control group [ Fig. 6(b) ] presented the same degradation behavior as CCPP scaffolds in solutionmediated degradation. However, all CCPP scaffolds in cell group showed similar degradation rates [ Fig. 6(a) ]. It might due to that CCPP scaffolds doped low-content copper ions (0.01% and 0.05%) could promote the proliferation of osteoblasts. Accordingly, there were more osteoblasts to secrete acidic metabolites on CCPP scaffolds doped low-content copper ions in cell group; therefore, the degradation of scaffolds could be enhanced, and CCPP scaffolds doped low-content copper ions in cell group showed a higher degradation rate which was According to the investigation performed by Meleti, 28 inorganic phosphate showed no cytotoxicity at phosphate concentrations of 1 mmol l À1 . Moreover, Wu 29 also found that PO 4 3À entered cells phosphate transporter to stimulate osteopontin (OPN) expression which played an important in the mineralization of osteoblast. Therefore, the cumulative phosphate ion release concentration during degradation in this paper showed no adverse inuence on the proliferation of osteoblast and could induce mineralization of osteoblast. The cumulative calcium ion release concentration during degradation ranged from 0.117 mg to 0.146 mg (5.85-7.3 mM). Maeno S. 30 suggested that 2-4 mM Ca 2+ was proper for survival and proliferation of osteoblasts, whereas slightly higher concentrations (6-8 mM) were in favor of osteoblast differentiation and matrix mineralization and higher concentrations (>10 mM) were cytotoxic. Also, Nakade 31 demonstrated that extracellular calcium ion played an important role in calcium hydroxide-induced calcication by modulating OPN and BMP-2 expression in cells. So, during 3 weeks of osteoblast-mediated degradation, the Ca 2+ released from CCPP scaffolds could induce the proliferation and mineralization of osteoblasts. The bioactivities of CCPP scaffolds depended largely on copper ions doped into them. Therefore, compared to Ca 2+ and PO 4
Analysis of the weight loss and ion release of CCPP scaffolds during osteoblast-mediated degradation. As shown in
3À
, Cu 2+ played a more important role in assessing the cytotoxicity of CCPP scaffolds. Jake found that the normal concentration of Cu 2+ was 0.0056-0.056 mg ml
À1
. 11 The cumulative Cu 2+ release concentration of CCPP scaffolds doped low-content copper ions (<0.1%) during osteoblast-mediated degradation was less than 0.0312 mg ml À1 , while the cumulative Cu 2+ release concentration of 0.5% CCPP scaffolds was 0.09948 mg ml À1 . It indicated that CCPP scaffolds doped high-content copper ions might show cytotoxicity on osteoblasts. In order to verify this presumption, the cytotoxicity of various CCPP was evaluated by MTT assay. The results were presented in Chapter 3.4 in this paper. Fig. 8(c)-(f) , aer immersing in the medium for 30 d, many pores were observed on the surface of scaffolds. It indicated that the scaffolds degraded in SBF and culture medium with osteoblast continuously with time. More signicant changes of surface morphology were observed on the surfaces of CCPP scaffolds in osteoblast-mediated degradation. Aer degrading in culture medium with osteoblast for 30 d, the crystal grains of CCPP had been degraded into smaller particles, and the crystal boundaries became blurred. To sum up, according to Fig. 8 and the results of weight loss and ion release above, we found out that CPP and CCPP scaffolds lost the weight and structures of scaffolds changed aer during solution-mediated and osteoblast-mediated degradation. Besides, the scaffolds in culture medium with osteoblast showed a higher degradation rate than those in SBF solution.
Morphology of CCPP
scaffolds before and aer 30 d degradation. As shown in
The cytocompatibility of CCPP scaffolds with MG63 human osteoblasts and HUVEC
The investigation on the cytocompatibility (cytotoxicity) of these CCPP scaffolds was performed in this chapter. Fig. 9 shows the effects of various CCPP scaffold material on osteoblast cells viability. As shown in Fig. 9 , all CCPP scaffolds could promote the proliferation of osteoblasts at 2, 4 and 6 days of culture. However, 0.2% CCPP and 0.5% CCPP scaffolds inhibited the proliferation of osteoblast while 0.01% CCPP, 0.05% CCPP and 0.1% CCPP scaffolds still enhanced osteoblast proliferation at 14 and 21 days of culture. It suggested that CCPP could accelerate the proliferation of osteoblasts, and it was a Cu dosedependent manner. CCPP scaffolds doped low-content copper ions showed a good osteoblasts-cytocompatibility. According to the results above, the compressive strength of CCPP scaffolds with the porosity of 70% was 5-9 MPa which met the strength requirements of cancellous bone (2-12 MPa) and the incorporation of Cu 2+ a could promote the degradation of CCPP scaffolds, we inferred that 0.05% CCPP was the optimal one. Bone growth greatly relies on the vascular network to transport nutrients/metabolites. 32 It is well known that the development of blood vessel always precedes the osteogenesis. 33 Under the circumstance of a well-developed vascular network, the osteoblasts produce osteoid, calcify and differentiate to osteocytes, and present healthy bone growth. Therefore, it is necessary to study on the effects of various CCPP scaffold materials on the viability of human vascular endothelial cells (HUVECs) which play a crucial role in the formation of new vascular network. Fig. 10 showed that all CCPP scaffolds could promote the proliferation of HUVECs at 2 and 4 days of culture. However, 0.5% CCPP scaffolds began to inhibit the proliferation of HUVEC at 6 days of culture. It indicated the acceleration of CCPP scaffolds for the proliferation of HUVECs with a Cu dosedependent manner similar to osteoblast cells. 0.05% CCPP was also the optimal one.
The reason for the cytocompatibility-results of these CCPP scaffolds might be due to that the cell-growth Fig. 9 The effects of various CCPP scaffold materials on osteoblast cells viability (* means the difference attained a statistically significant differences compared to the blank group; # means the difference attained a statistically significant differences compared to 0.05% group, p < 0.05, n ¼ 3). Fig. 10 The effects of various CCPP scaffold materials on HUVECs viability (# means the difference attained a statistically significant differences compared to 0.05% group, p < 0.05, n ¼ 3). from CCPP scaffolds doped low-content copper ions could enhance the proliferation of HUVECs and osteoblast. Hu found that copper could stimulates the proliferation of endothelial cell at the concentration of 500 mM aer 48 hours. 34 Ewald also found that copper could enhances the proliferation of osteoblastic cells on calcium phosphate cements (CPC) at the concentration of 0.56 mg cm À2 aer 10 days. 35 On the other hand, a high content of copper ions released from scaffolds might show cytotoxicity on HUVECs and osteoblasts, resulting in that 0.5% CCPP scaffolds inhibited the proliferation of HUVECs (aer 6 days) and osteoblast (aer 14 days). Fig. 9 and 10 both indicated that 0.05% CCPP scaffolds showed the best proliferation on MG63 and HUVECs. We further investigated the growth of cells (HUVECs and osteoblasts) on/within the 0.05% CCPP scaffolds by uorescence microscope [ Fig. 11 ]. Fig. 11 indicated the same results that 0.05% CCPP scaffolds could promote the proliferation of MG63 and HUVECs compared to CPP scaffolds. Moreover, there were more MG63 and HUVECs observed inside of 0.05% CCPP compared to CPP scaffolds. This might be due to that copper ions have the ability to induce endothelial cell migration. 36 Also, Fig. 12 shows the SEM images of MG63 and HUVEC cultured on the 0.05% CCPP scaffolds aer 21 days of culture. The adhered cells developed numerous cellular processes (lamellipodia and lopodia) to facilitate cell-substrate and cell-cell interactions. The lamellipodia structure could be noticed in the gure, which indicated the preferable, strong interactions between cells and CCPP. So we inferred that both MG63 and HUVEC had a good adhesion and growth on the 0.05% CCPP. Above all, 0.05% CCPP scaffolds could promote the proliferation and migration of MG63 and HUVECs, which indicate its potential osteogenesis and angiogenesis.
The effects of CPP and CCPP scaffolds on osteogenic and angiogenic growth factors secretion from osteoblasts/ endothelial cells
The results shown in Fig. 13 and 14 indicated that 0.05% CCPP scaffolds could promote the secretion of all these osteogenic Fig. 13 The effect of various CCPP scaffolds on VEGF secretion from HUVEC cultured with materials (# means the difference attained a statistically significant differences compared to 0.05% group, p < 0.05, n ¼ 3). Fig. 14 The effect of various CCPP scaffolds on VEGF, ALP and OCN secretion from MG63 cultured with materials (# means the difference attained a statistically significant differences compared to 0.05% group, p < 0.05, n ¼ 3).
and angiogenic growth factors obviously. Proper content copper ions released from 0.05% CCPP scaffolds might have active effects on the secretion of all these growth factors. However, 0.1%, 0.2%, 0.5% CCPP scaffolds released excessive copper ions, which resulted in cytotoxicity, and then inhibited the secretion of these growth factors from cells.
As we all know, doping Cu 2+ ions into bioactive scaffolds could mimick hypoxia and stabilize the expression of hypoxiainducible factor (HIF-1a). 15 It has been generally acknowledged that HIF-1a plays an important role in stimulating cells to express VEGF.
37 HIF-1a acts as a promoter for VEGF gene, it can induce the expression of VEGF in hypoxia conditions. Therefore, 0.05% CCPP scaffolds could promote the secretion of VEGF from HUVECs/osteoblasts. VEGF is a very important angiogenic growth factor which activates endothelial cells in the surrounding tissues by regulating their proliferation, migration, and nally promotes the formation of tubular structures.
38
In addition, the investigation undertaken by Wu 15 indicated that the copper ions could promote the expression of bonerelated gene such as OCN, OPN and ALP. This could be the reason for the better promotion of 0.05% CCPP scaffolds on the secretion of ALP and OCN from MG63. OCN is known as a key marker for osteogenic differentiation and ALP, which is expressed during the post-proliferative period of extracellularmatrix maturation, has been widely recognized as a marker for osteoblast differentiation. So, it is concluded that 0.05% CCPP scaffolds show a notable ability to stimulate osteogenesis, which plays a crucial role in the formation of new bone. As mentioned in introduction, the energy produced by the breakage of P\O\P bonds between [PO 3 À ] units in CCPP, which was similar to the breaking of high-energy anhydride linkages in the adenosine triphosphate, could be used for cell-growth, which might also be the reason why 0.05% CCPP could promote the secretion of all these growth factors. Compared with other Cu-containing biomaterials such as copper-doped hydroxyapatite, 0.05% CCPP scaffolds showed better cytocompatibility and ability to stimulate osteogenesis and angiogenesis due to the synergy effects of copper and the energy produced by the breakage of P\O\P bonds between [PO 3 À ] units in CCPP. In summary, the results obtained in this study suggested that 0.05% CCPP scaffold was a promising biomaterial for bone repairing application.
Conclusion
In this paper, a novel Cu-containing porous scaffold, namely copper-doped calcium polyphosphate, was successfully prepared, and its biological performances and degradation behavior in vitro were investigated. The results suggested that low-content copper doping showed no signicant inuence on the structure of CPP scaffolds. The compressive strength of CCPP scaffolds with the porosity of 70% was 5-9 MPa which met the strength requirements of cancellous bone (2-12 MPa). In degradation experiment, the results suggested that both the incorporation of Cu 2+ and acidic metabolites from osteoblasts could promote the degradation of CCPP scaffolds. Also, analysis of the concentration of Cu
2+
, Ca 2+ and PO 4 3À released from various scaffolds in osteoblast-mediated degradation was performed to elucidate the cytocompatibility of CCPP scaffolds with HUVECs/osteoblasts, and then their osteogenic and angiogenic properties were exploited. The results demonstrated that 0.05% CCPP scaffolds showed the good promotion on the proliferation of MG63 and HUVEC. The results also suggested that 0.05% CCPP scaffold could promote the secretion of VEGF, ALP and OCN from osteoblasts as well as VEGF from HUVECs, which indicated its good ability to stimulate osteogenesis and angiogenesis. All results obtained in our study suggest that 0.05% CCPP scaffold is a promising biomaterial for bone repairing application. We believe that our research provides a way to improve the properties of bioceramics and extend the applications of bone tissue engineering. It can give inspiration to others to focus on the applications and development of bioceramics.
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